AdaptHealth Corp.
AdaptHealth Corp. (AHCO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ahco · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for AdaptHealth Corp. (AHCO) measures how much investors pay for each dollar of the company's trailing earnings. AHCO's current PE ratio of N/A is calculated by dividing its stock price of $9.66 by its TTM earnings per share of -$0.59.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%28.5x
MedianQ3 · 75%147.3x
Max
At N/A, AHCO's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
AdaptHealth Corp.You AHCO | $1.3B | N/A | — | -$0.59 |
 Amphastar Pharmaceuticals, Inc. AMPH | $859M | 12.76x | -24.4% | $2.10 |
 Beta Bionics, Inc. BBNX | $633M | N/A | — | -$1.81 |
 CONMED Corporation CNMD | $1.0B | 26.78x | +58.6% | $1.52 |
 CureVac N.V. CVAC | $1.0B | 4.56x | -73.0% | $0.72 |
 Establishment Labs Holdings Inc. ESTA | $2.2B | N/A | — | -$1.72 |
 Healthcare Services Group, Inc. HCSG | $1.4B | 23.43x | +38.8% | $0.82 |
Industry Average 4 peers with valid PE | — | 16.88x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.52 | — | |
2024-12-31 FY2024 | 14.08x | $0.68 | — | |
2023-12-31 FY2023 | — | $-5.06 | — | |
2022-12-31 FY2022 | 37.20x | $0.52 | +88.1% | |
2021-12-31 FY2021 | 19.78x | $1.24 | — | |
2020-12-31 FY2020 | — | $-3.08 | — | |
2019-12-31 FY2019 | — | $-0.29 | — | |
2018-12-31 FY2018 | 147.25x | $0.07 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.12 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for AdaptHealth Corp. (AHCO) measures how much investors pay for each dollar of the company's trailing earnings. AHCO's current PE ratio of N/A is calculated by dividing its stock price of $9.66 by its TTM earnings per share of -$0.59.
Frequently asked questions
AHCO pe ratio · 6 questionsAHCO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $9.66 and TTM EPS of -$0.59. Data sourced from Financial Modeling Prep via AHCO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · AdaptHealth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08